Company preparing FDA meeting package to align on a single, well-controlled Phase 3 study under 505(b)(2); Pharma partner ...

The FDA has named the first nine medications selected for its national priority review voucher program, which aims to shorten drug review timelines to ...

PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty life sciences company ...

Combining psychotherapy with low-dose ketamine is a relatively new approach to treating severe depression and post-traumatic ...

The FDA in June launched the new Commissioner's National Priority Voucher pilot program under which it could issue vouchers ...

The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically ...

Ketamine clinics have been growing in popularity as an alternative depression treatment, but after the death of celebrity ...

Ministers said there were also growing concerns about THC vapes laced with ‘spice’, as well as synthetic opioids being sold ...

For many people living with depression, the road to feeling better can be long and sometimes discouraging. So many paths to ...

University life's celebrations can take a dangerous turn with the rise of ketamine use among young adults. This dissociative ...

When used for mental health treatment, a dose of ketamine — typically half a milligram per kilogram of body weight, less than ...